Long-Term Debt Maturities

Entity Registrant Name CARDINAL HEALTH INC
CIK 0000721371
Accession number 0000721371-14-000181
Link to XBRL instance http://www.sec.gov/Archives/edgar/data/721371/000072137114000181/cah-20140630.xml
Fiscal year end --06-30
Fiscal year focus 2014
Fiscal period focus FY
Current balance sheet date 2014-06-30
Current year-to-date income statement start date 2013-07-01

Commentary Filer provides a narrative for the disclosure, but does not include a text block: Maturities of long-term obligations and other short-term borrowings for fiscal 2015 through 2019 and thereafter are as follows: $801 million, $22 million, $788 million, $561 million, $1 million and $1,799 million.

Level 1 (Note level) Text Block concept us-gaap:DebtDisclosureTextBlock
Long-Term Obligations and Other Short-Term Borrowings
The following table summarizes long-term obligations and other short-term borrowings at June 30:
(in millions)
2014
 
2013
1.7% Notes due 2018
$
401

 
$
399

1.9% Notes due 2017
251

 
250

3.2% Notes due 2022
248

 
247

3.2% Notes due 2023
549

 
549

4.0% Notes due 2015
513

 
524

4.6% Notes due 2043
349

 
349

4.625% Notes due 2020
525

 
527

5.8% Notes due 2016
301

 
301

5.85% Notes due 2017
158

 
157

6.0% Notes due 2017
197

 
200

7.0% Debentures due 2026
124

 
124

7.8% Debentures due 2016
37

 
37

Other obligations
319

 
190

Total
$
3,972

 
$
3,854

Less: current portion of long-term obligations and other short-term borrowings
801

 
168

Long-term obligations, less current portion
$
3,171

 
$
3,686


Maturities of long-term obligations and other short-term borrowings for fiscal 2015 through 2019 and thereafter are as follows: $801 million, $22 million, $788 million, $561 million, $1 million and $1,799 million.
Long-Term Debt
The 1.7%, 1.9%, 3.2%, 4.0%, 4.6%, 4.625%, 5.8%, 5.85% and 6.0% Notes represent unsecured obligations of Cardinal Health, Inc. The 7.0% and 7.8% Debentures represent unsecured obligations of Allegiance Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligations are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid pursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our subsidiaries, including trade payables of $12.1 billion.
In June 2013, we used cash on hand to repay $300 million of our 5.5% Notes that were due on June 15, 2013.
In February 2013, we sold in a registered offering $400 million aggregate principal amount of 1.7% Notes that mature on March 15, 2018, $550 million aggregate principal amount of 3.2% Notes that mature on March 15, 2023 and $350 million aggregate principal amount of 4.6% Notes that mature on March 15, 2043. These notes are unsecured obligations and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness. We used the proceeds to fund a portion of the purchase price of AssuraMed as discussed in Note 2.
In May 2012, we sold in a registered offering $250 million aggregate principal amount of 1.9% Notes that mature on June 15, 2017 and $250 million aggregate principal amount of 3.2% Notes that mature on June 15, 2022. These notes are unsecured and unsubordinated obligations and rank equally in right of payment with all of our existing and future unsecured and unsubordinated indebtedness.
The 6.0% Notes due 2017, 1.9% Notes due 2017, 1.7% Notes due 2018, 4.625% Notes due 2020, 3.2% Notes due 2022, 3.2% Notes due 2023 and 4.6% Notes due 2043 require us to offer to purchase the notes at 101% of the principal amount plus accrued and unpaid interest, if we have a defined change of control and specified ratings below investment grade by Standard & Poor's Ratings Services, Moody's Investors Service, Inc. and Fitch Ratings.
Other Financing Arrangements
In addition to cash and equivalents, at June 30, 2014 and 2013, our sources of liquidity include a $1.5 billion revolving credit facility and a commercial paper program of up to $1.5 billion, backed by the revolving credit facility. The revolving credit facility exists largely to support issuances of commercial paper as well as other short-term borrowings for general corporate purposes.
On November 6, 2012, we renewed our $950 million committed receivables sales facility program through Cardinal Health Funding, LLC ("CHF") until November 6, 2014. On October 15, 2013, we reduced our committed receivables sales facility program from $950 million to $700 million in light of the Walgreens contract expiration. CHF was organized for the sole purpose of buying receivables and selling undivided interests in those receivables to third-party purchasers. Although consolidated in accordance with GAAP, CHF is a separate legal entity from Cardinal Health and from our subsidiary that sells the receivables to CHF. CHF is designed to be a special purpose, bankruptcy-remote entity whose assets are available solely to satisfy the claims of its creditors.
We had no outstanding balance under the revolving credit facility at June 30, 2014 and 2013, except for standby letters of credit of zero and $43 million at June 30, 2014 and 2013, respectively. We had no outstanding borrowings from the commercial paper program at June 30, 2014 and 2013. We had no outstanding balance under the committed receivables sales facility program at June 30, 2014 and 2013, except for standby letters of credit of $41 million and zero at June 30, 2014 and 2013, respectively. Our revolving credit facility and committed receivables sales facility program require us to maintain a consolidated interest coverage ratio, as of any fiscal quarter end, of at least 4-to-1 and a consolidated leverage ratio of no more than 3.25-to-1. As of June 30, 2014, we were in compliance with these financial covenants.
We also maintain other short-term credit facilities and an unsecured line of credit that allowed for borrowings up to $369 million and $304 million at June 30, 2014 and 2013, respectively. The $319 million and $190 million balance of other obligations at June 30, 2014 and 2013, respectively, consisted of short-term borrowings and capital leases.
Level 4 (Note level) Text Block concept - Maturities of Long Term Debt Filer provides maturities in textual form, therefore provides no text block
Filer provides maturities in textual form, therefore provides no text block
Level 4 (Note level) Text Block concept - Debt Instruments us-gaap:ScheduleOfDebtTableTextBlock
The following table summarizes long-term obligations and other short-term borrowings at June 30:
(in millions)
2014
 
2013
1.7% Notes due 2018
$
401

 
$
399

1.9% Notes due 2017
251

 
250

3.2% Notes due 2022
248

 
247

3.2% Notes due 2023
549

 
549

4.0% Notes due 2015
513

 
524

4.6% Notes due 2043
349

 
349

4.625% Notes due 2020
525

 
527

5.8% Notes due 2016
301

 
301

5.85% Notes due 2017
158

 
157

6.0% Notes due 2017
197

 
200

7.0% Debentures due 2026
124

 
124

7.8% Debentures due 2016
37

 
37

Other obligations
319

 
190

Total
$
3,972

 
$
3,854

Less: current portion of long-term obligations and other short-term borrowings
801

 
168

Long-term obligations, less current portion
$
3,171

 
$
3,686


Level 4 Details Key Concepts: Long-term Debt Maturities

Description Fact value US GAAP XBRL Concept
Year 1 (Current portion) 801,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
Year 2 22,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
Year 3 788,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
Year 4 561,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
Year 5 1,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
Thereafter 1,799,000,000 us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
Total Long-term Debt 3,972,000,000 us-gaap:DebtAndCapitalLeaseObligations
CHECK 0

*


(Classified balance sheet) Deferred tax assets (liabilities), net components current/noncurrent asset/liability

Description Fact value US GAAP XBRL Concept
Current portion 801,000,000 us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
Noncurrent portion 3,171,000,000 us-gaap:LongTermDebtAndCapitalLeaseObligations
Total Long-Term Debt 3,972,000,000 us-gaap:DebtAndCapitalLeaseObligations
CHECK 0

*


*

Creative Commons License
This work is licensed under a Creative Commons License.


Valid CSS!